Hannah Valantine

Hannah Valantine

Director/Board Member chez CAREDX, INC

Fortune : 445 467 $ au 31/03/2024

72 ans
Health Technology
Consumer Services
Commercial Services

Profil

Hannah A.
Valantine
is the founder of Hav LLC, a company founded in 2021 where she holds the title of Principal.
She is currently working as an Independent Director at CareDx, Inc., Pacific Biosciences of California, Inc., and BridgeBio Pharma, Inc., all since 2021.
Additionally, she is a Professor at Stanford University School of Medicine since 1987 and a Member of the National Academy of Medicine (United States).
Dr. Valantine completed her undergraduate and doctorate degrees at the University of London and also holds an undergraduate degree from Chelsea College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/06/2023 26 891 ( 0,05% ) 284 776 $ 31/03/2024
15/02/2024 5 197 ( 0,00% ) 160 691 $ 31/03/2024
31/03/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Hannah Valantine

SociétésPosteDébut
CAREDX, INC Director/Board Member 01/07/2021
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Director/Board Member 16/06/2021
BRIDGEBIO PHARMA, INC. Director/Board Member 23/10/2021
Stanford University School of Medicine Corporate Officer/Principal 01/01/1987
Hav LLC Founder 01/01/2021
Corporate Officer/Principal -
Tous les postes actifs de Hannah Valantine

Formation de Hannah Valantine

University of London Doctorate Degree
Chelsea College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Hannah Valantine

Relations

100 +

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
CAREDX, INC

Health Technology

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Health Technology

BRIDGEBIO PHARMA, INC.

Health Technology

Entreprise privées2

Commercial Services

Hav LLC

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Hannah Valantine